サインバルタカプセル２０ｍｇ
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB00476 |
| エビデンスレベル | L5（計算予測のみ） |
| 予測適応症数 | 56 |
| 日本商品名（例） | サインバルタカプセル２０ｍｇ, サインバルタカプセル２０ｍｇ（選）, サインバルタカプセル３０ｍｇ |
予測適応症（TxGNN）
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | major depressive disorder | 99% | DL |
| 2 | unipolar depression | 99% | DL |
| 3 | anxiety disorder | 99% | DL |
| 4 | endogenous depression | 99% | DL |
| 5 | myofascial pain syndrome | 99% | DL |
| 6 | benign paroxysmal torticollis of infancy | 99% | DL |
| 7 | agoraphobia | 99% | DL |
| 8 | obsessive-compulsive disorder | 99% | DL |
| 9 | schizotypal personality disorder | 99% | DL |
| 10 | schizoid personality disorder | 99% | DL |
| 11 | paranoid personality disorder | 99% | DL |
| 12 | histrionic personality disorder (disease) | 99% | DL |
| 13 | Ohdo syndrome and variants | 99% | DL |
| 14 | ligneous conjunctivitis | 99% | DL |
| 15 | blepharophimosis - intellectual disability syndrome, Ohdo type | 99% | DL |
| 16 | dysthymic disorder | 99% | DL |
| 17 | melancholia | 99% | DL |
| 18 | neurotic depression | 99% | DL |
| 19 | phobic disorder | 99% | DL |
| 20 | childhood apraxia of speech | 99% | DL |
| 21 | Keppen-Lubinsky syndrome | 99% | DL |
| 22 | surfactant metabolism dysfunction, pulmonary | 98% | DL |
| 23 | post-traumatic stress disorder | 98% | DL |
| 24 | neurotic disorder | 98% | DL |
| 25 | chromosome 15q26-qter deletion syndrome | 98% | DL |
| 26 | dependent personality disorder | 98% | DL |
| 27 | congenital isolated adrenocorticotropic hormone deficiency (disease) | 98% | DL |
| 28 | autosomal dominant slowed nerve conduction velocity | 98% | DL |
| 29 | narcissistic personality disorder | 98% | DL |
| 30 | migraine with brainstem aura | 98% | DL |
| 31 | migraine disorder | 98% | DL |
| 32 | vitamin B12-responsive methylmalonic acidemia | 97% | DL |
| 33 | manic bipolar affective disorder | 97% | DL |
| 34 | avoidant personality disorder | 97% | DL |
| 35 | tendinitis | 96% | DL |
| 36 | idiopathic granulomatous myositis | 96% | DL |
| 37 | myositis fibrosa | 96% | DL |
| 38 | Asperger syndrome | 96% | DL |
| 39 | major affective disorder | 95% | DL |
| 40 | osteoarthritis susceptibility | 95% | DL |
| 41 | atrophoderma vermiculata | 95% | DL |
| 42 | coronary aneurysm | 95% | DL |
| 43 | fibromyalgia | 94% | DL |
| 44 | mixed anxiety and depressive disorder | 94% | DL |
| 45 | osteoarthritis | 93% | DL |
| 46 | ulerythema ophryogenesis | 93% | DL |
| 47 | inclusion body myositis | 93% | DL |
| 48 | familial hypertryptophanemia | 93% | DL |
| 49 | schizophrenia | 91% | DL |
| 50 | acromesomelic dysplasia, Hunter-Thompson type | 91% | DL |
（上位50件を表示。全56件の予測があります）
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。